{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_avacopan",
          "type": "Drug",
          "label": "Avacopan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_furosemide",
          "type": "Drug",
          "label": "Furosemide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_amlodipine",
          "type": "Drug",
          "label": "Amlodipine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_steroids",
          "type": "Drug",
          "label": "Steroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_angiotensin_ii_receptor_blockers",
          "type": "Drug",
          "label": "Angiotensin II receptor blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rasburicase",
          "type": "Drug",
          "label": "Rasburicase",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_caplacizumab",
          "type": "Drug",
          "label": "Caplacizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_defibrotide",
          "type": "Drug",
          "label": "Defibrotide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "diseases_Atypical_HUS",
          "type": "Disease",
          "label": "Atypical haemolytic uraemic syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_eculizumab",
          "type": "Target",
          "label": "Eculizumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_eculizumab",
          "type": "Pathway",
          "label": "Eculizumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_eculizumab",
          "type": "Phenotype",
          "label": "Eculizumab Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ravulizumab",
          "type": "Target",
          "label": "Ravulizumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ravulizumab",
          "type": "Pathway",
          "label": "Ravulizumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ravulizumab",
          "type": "Phenotype",
          "label": "Ravulizumab Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_avacopan",
          "type": "Target",
          "label": "Avacopan Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_avacopan",
          "type": "Pathway",
          "label": "Avacopan Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_avacopan",
          "type": "Phenotype",
          "label": "Avacopan Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_furosemide",
          "type": "Target",
          "label": "Furosemide Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_furosemide",
          "type": "Pathway",
          "label": "Furosemide Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_furosemide",
          "type": "Phenotype",
          "label": "Furosemide Adverse Phenotype",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_eculizumab",
          "target": "diseases_Atypical_HUS",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "已知用于治疗特定类型的HUS"
        },
        {
          "source": "drug_ravulizumab",
          "target": "diseases_Atypical_HUS",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与Eculizumab相似的机制"
        },
        {
          "source": "drug_avacopan",
          "target": "diseases_Atypical_HUS",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "潜在应用于肾脏相关病症"
        },
        {
          "source": "drug_furosemide",
          "target": "diseases_Atypical_HUS",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "糖尿病引起的并发症管理常用药物"
        },
        {
          "source": "drug_amlodipine",
          "target": "diseases_Atypical_HUS",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "管理高血压时可能使用"
        },
        {
          "source": "drug_steroids",
          "target": "diseases_Atypical_HUS",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "免疫介导的病症常见治疗"
        },
        {
          "source": "drug_angiotensin_ii_receptor_blockers",
          "target": "diseases_Atypical_HUS",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "用于相关的高血压情况"
        },
        {
          "source": "drug_rasburicase",
          "target": "diseases_Atypical_HUS",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能影响代谢状态的药物"
        },
        {
          "source": "drug_caplacizumab",
          "target": "diseases_Atypical_HUS",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "已显示在HUS中的疗效"
        },
        {
          "source": "drug_sirolimus",
          "target": "diseases_Atypical_HUS",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "在一些病理生理状态中的用途"
        },
        {
          "source": "drug_defibrotide",
          "target": "diseases_Atypical_HUS",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "对某些血管病变可能有效"
        },
        {
          "source": "drug_corticosteroids",
          "target": "diseases_Atypical_HUS",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "用于管理免疫反应的药物"
        },
        {
          "source": "drug_eculizumab",
          "target": "n_ot_eculizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_eculizumab",
          "target": "n_rp_eculizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_eculizumab",
          "target": "n_adv_eculizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_eculizumab",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险影响净获益"
        },
        {
          "source": "drug_ravulizumab",
          "target": "n_ot_ravulizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_ravulizumab",
          "target": "n_rp_ravulizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_ravulizumab",
          "target": "n_adv_ravulizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_ravulizumab",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险影响净获益"
        },
        {
          "source": "drug_avacopan",
          "target": "n_ot_avacopan",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_avacopan",
          "target": "n_rp_avacopan",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_avacopan",
          "target": "n_adv_avacopan",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_avacopan",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险影响净获益"
        },
        {
          "source": "drug_furosemide",
          "target": "n_ot_furosemide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的旁路作用"
        },
        {
          "source": "n_ot_furosemide",
          "target": "n_rp_furosemide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "关联的风险路径"
        },
        {
          "source": "n_rp_furosemide",
          "target": "n_adv_furosemide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致不良表型"
        },
        {
          "source": "n_adv_furosemide",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "风险影响净获益"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.54,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.9,
            "safety_risk": 0.3,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.06
          },
          "graph_signals": {
            "support_weight": 0.85,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Eculizumab efficacy vs adverse effects",
                "pro": [
                  "drug_eculizumab"
                ],
                "con": [
                  "n_adv_eculizumab"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Eculizumab已知用于治疗特定类型的HUS"
            ],
            "safety_risk": [
              "Skeptic指向潜在的不良表型影响"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "缺乏具体的机制路径",
            "用途与风险之间的平衡需要进一步考证"
          ]
        },
        {
          "hypothesis_id": "H2",
          "score": 0.54,
          "components": {
            "mechanism_fit": 0.8,
            "class_prior": 0.8,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.9,
            "safety_risk": 0.3,
            "graph_bonus": 0.25,
            "conflict_penalty": 0.06
          },
          "graph_signals": {
            "support_weight": 0.85,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Ravulizumab efficacy vs adverse effects",
                "pro": [
                  "drug_ravulizumab"
                ],
                "con": [
                  "n_adv_ravulizumab"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "与Eculizumab相似的机制"
            ],
            "safety_risk": [
              "Skeptic指向潜在的不良表型影响"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "缺乏具体的机制路径",
            "用途与风险之间的平衡需要进一步考证"
          ]
        },
        {
          "hypothesis_id": "H3",
          "score": 0.52,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.7,
            "safety_risk": 0.3,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Avacopan efficacy vs adverse effects",
                "pro": [
                  "drug_avacopan"
                ],
                "con": [
                  "n_adv_avacopan"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "潜在应用于肾脏相关病症"
            ],
            "safety_risk": [
              "Skeptic指向潜在的不良表型影响"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "缺乏具体的机制路径",
            "用途与风险之间的平衡需要进一步考证"
          ]
        },
        {
          "hypothesis_id": "H4",
          "score": 0.38,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.6,
            "safety_risk": 0.3,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Furosemide efficacy vs adverse effects",
                "pro": [
                  "drug_furosemide"
                ],
                "con": [
                  "n_adv_furosemide"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "糖尿病引起的并发症管理常用药物"
            ],
            "safety_risk": [
              "Skeptic指向潜在的不良表型影响"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "治疗效果的不确定性",
            "可能的负面安全影响"
          ]
        },
        {
          "hypothesis_id": "H5",
          "score": 0.32,
          "components": {
            "mechanism_fit": 0.4,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.4,
            "safety_risk": 0.3,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Amlodipine efficacy vs adverse effects",
                "pro": [
                  "drug_amlodipine"
                ],
                "con": [
                  "n_adv_amlodipine"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "管理高血压时可能使用"
            ],
            "safety_risk": [
              "Skeptic指向潜在的不良表型影响"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "缺乏强证据",
            "安全性风险的平衡"
          ]
        },
        {
          "hypothesis_id": "H6",
          "score": 0.48,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.5,
            "safety_risk": 0.4,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "免疫介导的病症常见治疗"
            ],
            "safety_risk": [
              "Skeptic指向潜在的不良反应风险"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "使用时应注意潜在风险"
          ]
        },
        {
          "hypothesis_id": "H7",
          "score": 0.34,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.4,
            "safety_risk": 0.3,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.55,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "用于相关的高血压情况"
            ],
            "safety_risk": [
              "Skeptic指向潜在的不良反应风险"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "缺乏针对HUS的支持证据"
          ]
        },
        {
          "hypothesis_id": "H8",
          "score": 0.33,
          "components": {
            "mechanism_fit": 0.4,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.4,
            "safety_risk": 0.3,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "可能影响代谢状态的药物"
            ],
            "safety_risk": [
              "Skeptic指向潜在的不良反应风险"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "缺乏针对HUS的支持证据"
          ]
        },
        {
          "hypothesis_id": "H9",
          "score": 0.52,
          "components": {
            "mechanism_fit": 0.7,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.7,
            "safety_risk": 0.3,
            "graph_bonus": 0.2,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Caplacizumab efficacy vs adverse effects",
                "pro": [
                  "drug_caplacizumab"
                ],
                "con": [
                  "n_adv_caplacizumab"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "已显示在HUS中的疗效"
            ],
            "safety_risk": [
              "Skeptic指向潜在的不良表型影响"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "缺乏明确的机制路径"
          ]
        },
        {
          "hypothesis_id": "H10",
          "score": 0.3,
          "components": {
            "mechanism_fit": 0.4,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.2,
            "indication_plausibility": 0.3,
            "safety_risk": 0.3,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.4,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "在一些病理生理状态中的用途"
            ],
            "safety_risk": [
              "Skeptic指向潜在的不良风险"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "缺乏针对HUS的强支持证据"
          ]
        },
        {
          "hypothesis_id": "H11",
          "score": 0.28,
          "components": {
            "mechanism_fit": 0.3,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.2,
            "indication_plausibility": 0.3,
            "safety_risk": 0.3,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.45,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "对某些血管病变可能有效"
            ],
            "safety_risk": [
              "Skeptic指向潜在的不良风险"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "缺乏针对HUS的强支持证据"
          ]
        },
        {
          "hypothesis_id": "H12",
          "score": 0.45,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.2,
            "indication_plausibility": 0.5,
            "safety_risk": 0.4,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.08
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.8,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "用于管理免疫反应的药物"
            ],
            "safety_risk": [
              "Skeptic指向潜在的不良反应风险"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "使用时应注意潜在风险"
          ]
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_eculizumab",
            "via": [
              "n_ot_eculizumab"
            ],
            "to": "diseases_Atypical_HUS",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "stress_test_safety",
            "topic": "Eculizumab Adverse Phenotype",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          },
          {
            "type": "merge_claims",
            "nodes": [
              "drug_eculizumab",
              "drug_ravulizumab"
            ],
            "rationale": "两者在机制上相似，可能简化冲突",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "Eculizumab的机制与副作用关系",
          "是否存在替代疗法的风险评估"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_ravulizumab",
            "via": [
              "n_ot_ravulizumab"
            ],
            "to": "diseases_Atypical_HUS",
            "success_criteria": "形成至少2条不相交路径",
            "assignee": "Proponent"
          },
          {
            "type": "stress_test_safety",
            "topic": "Ravulizumab Adverse Phenotype",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Ravulizumab的风险-效益比",
          "与Eculizumab的比较"
        ]
      }
    ],
    "pruned_hypotheses": [
      "H5",
      "H6",
      "H10",
      "H11",
      "H12"
    ],
    "new_subhypotheses": [],
    "seed_request": {
      "should_regenerate": false,
      "reason": "现有候选的机制连接性不足，冲突集中在Eculizumab与Ravulizumab的安全性问题，建议通过补链与去冗余提升。\n",
      "n": 4
    }
  }
}